Literature DB >> 15557669

Anaplasma marginale major surface protein 2 CD4+-T-cell epitopes are evenly distributed in conserved and hypervariable regions (HVR), whereas linear B-cell epitopes are predominantly located in the HVR.

Jeffrey R Abbott1, Guy H Palmer, Chris J Howard, Jayne C Hope, Wendy C Brown.   

Abstract

Organisms in the genus Anaplasma express an immunodominant major surface protein 2 (MSP2), composed of a central hypervariable region (HVR) flanked by highly conserved regions. Throughout Anaplasma marginale infection, recombination results in the sequential appearance of novel MSP2 variants and subsequent control of rickettsemia by the immune response, leading to persistent infection. To determine whether immune evasion and selection for variant organisms is associated with a predominant response against HVR epitopes, T-cell and linear B-cell epitopes were localized by measuring peripheral blood gamma interferon-secreting cells, proliferation, and antibody binding to 27 overlapping peptides spanning MSP2 in 16 cattle. Similar numbers of MSP2-specific CD4(+) T-cell epitopes eliciting responses of similar magnitude were found in conserved and hypervariable regions. T-cell epitope clusters recognized by the majority of animals were identified in the HVR (amino acids [aa] 171 to 229) and conserved regions (aa 101 to 170 and 272 to 361). In contrast, linear B-cell epitopes were concentrated in the HVR, residing within hydrophilic sequences. The pattern of recognition of epitope clusters by T cells and of HVR epitopes by B cells is consistent with the influence of protein structure on epitope recognition.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15557669      PMCID: PMC529150          DOI: 10.1128/IAI.72.12.7360-7366.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Unique T cell effector functions elicited by Plasmodium falciparum epitopes in malaria-exposed Africans tested by three T cell assays.

Authors:  K L Flanagan; E A Lee; M B Gravenor; W H Reece; B C Urban; T Doherty; K A Bojang; M Pinder; A V Hill; M Plebanski
Journal:  J Immunol       Date:  2001-10-15       Impact factor: 5.422

2.  Persistent Ehrlichia chaffeensis infection occurs in the absence of functional major histocompatibility complex class II genes.

Authors:  Roman Reddy Ganta; Melinda J Wilkerson; Chuanmin Cheng; Aaron M Rokey; Stephen K Chapes
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

3.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

4.  Expression of major surface protein 2 variants with conserved T-cell epitopes in Anaplasma centrale vaccinates.

Authors:  Varda Shkap; Thea Molad; Kelly A Brayton; Wendy C Brown; Guy H Palmer
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

5.  Highly conserved regions of the immunodominant major surface protein 2 of the genogroup II ehrlichial pathogen Anaplasma marginale are rich in naturally derived CD4+ T lymphocyte epitopes that elicit strong recall responses.

Authors:  W C Brown; T C McGuire; D Zhu; H A Lewin; J Sosnow; G H Palmer
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

6.  Immunopathology and ehrlichial propagation are regulated by interferon-gamma and interleukin-10 in a murine model of human granulocytic ehrlichiosis.

Authors:  M E Martin; K Caspersen; J S Dumler
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

7.  Antigenic variation of Anaplasma marginale by expression of MSP2 mosaics.

Authors:  A F Barbet; A Lundgren; J Yi; F R Rurangirwa; G H Palmer
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

8.  Simultaneous variation of the immunodominant outer membrane proteins, MSP2 and MSP3, during anaplasma marginale persistence in vivo.

Authors:  Kelly A Brayton; Patrick F M Meeus; Anthony F Barbet; Guy H Palmer
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

9.  CD4+ T lymphocytes from Anaplasma marginale major surface protein 2 (MSP2) vaccinees recognize naturally processed epitopes conserved in MSP3.

Authors:  Wendy C Brown; Guy H Palmer; Kelly A Brayton; Patrick F M Meeus; Anthony F Barbet; Kimberly A Kegerreis; Travis C McGuire
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

10.  Magnetic microspheres and monoclonal antibodies for the depletion of neuroblastoma cells from bone marrow: experiences, improvements and observations.

Authors:  J T Kemshead; L Heath; F M Gibson; F Katz; F Richmond; J Treleaven; J Ugelstad
Journal:  Br J Cancer       Date:  1986-11       Impact factor: 7.640

View more
  19 in total

1.  Cooperation of PD-1 and LAG-3 Contributes to T-Cell Exhaustion in Anaplasma marginale-Infected Cattle.

Authors:  Tomohiro Okagawa; Satoru Konnai; James R Deringer; Massaro W Ueti; Glen A Scoles; Shiro Murata; Kazuhiko Ohashi; Wendy C Brown
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

2.  Identification of Anaplasma marginale outer membrane protein antigens conserved between A. marginale sensu stricto strains and the live A. marginale subsp. centrale vaccine.

Authors:  Joseph T Agnes; Kelly A Brayton; Megan LaFollett; Junzo Norimine; Wendy C Brown; Guy H Palmer
Journal:  Infect Immun       Date:  2010-12-28       Impact factor: 3.441

3.  Immunogenicity of hypothetical highly conserved proteins as novel antigens in Anaplasma marginale.

Authors:  Pablo A Nuñez; Rosalia Moretta; Paula Ruybal; Silvina Wilkowsky; Marisa D Farber
Journal:  Curr Microbiol       Date:  2013-10-15       Impact factor: 2.188

4.  Identification of a T-Cell Epitope That Is Globally Conserved among Outer Membrane Proteins (OMPs) OMP7, OMP8, and OMP9 of Anaplasma marginale Strains and with OMP7 from the A. marginale subsp. centrale Vaccine Strain.

Authors:  James R Deringer; Elkin G Forero-Becerra; Massaro W Ueti; Joshua E Turse; James E Futse; Susan M Noh; Guy H Palmer; Wendy C Brown
Journal:  Clin Vaccine Immunol       Date:  2017-01-05

5.  The immunization-induced antibody response to the Anaplasma marginale major surface protein 2 and its association with protective immunity.

Authors:  Susan M Noh; Yan Zhuang; James E Futse; Wendy C Brown; Kelly A Brayton; Guy H Palmer
Journal:  Vaccine       Date:  2010-03-01       Impact factor: 3.641

6.  Primary Structural Variation in Anaplasma marginale Msp2 Efficiently Generates Immune Escape Variants.

Authors:  Telmo Graça; Lydia Paradiso; Shira L Broschat; Susan M Noh; Guy H Palmer
Journal:  Infect Immun       Date:  2015-08-10       Impact factor: 3.441

7.  Antigenic Variation in Bacterial Pathogens.

Authors:  Guy H Palmer; Troy Bankhead; H Steven Seifert
Journal:  Microbiol Spectr       Date:  2016-02

8.  Two monoclonal antibodies with defined epitopes of P44 major surface proteins neutralize Anaplasma phagocytophilum by distinct mechanisms.

Authors:  Xueqi Wang; Takane Kikuchi; Yasuko Rikihisa
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

9.  Maintenance of antibody to pathogen epitopes generated by segmental gene conversion is highly dynamic during long-term persistent infection.

Authors:  Yan Zhuang; James E Futse; Wendy C Brown; Kelly A Brayton; Guy H Palmer
Journal:  Infect Immun       Date:  2007-09-04       Impact factor: 3.441

10.  Immunization-induced Anaplasma marginale-specific T-lymphocyte responses impaired by A. marginale infection are restored after eliminating infection with tetracycline.

Authors:  Joshua E Turse; Glen A Scoles; James R Deringer; Lindsay M Fry; Wendy C Brown
Journal:  Clin Vaccine Immunol       Date:  2014-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.